Glucose Health Inc (GLUC) 0.1200 $GLUC Glucose Health(R)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Glucose Health Inc (GLUC) 0.1200 $GLUC

Glucose Health(R) - New Product for Pre & Type-2 Diabetes Now Available at Walmart
BusinessWire - Mon Jun 20, 6:45AM CDT
Glucose Health, Inc. (OTC: GLUC) today announced its innovative, non-prescription dietary supplement, formulated for persons with pre and Type-2 diabetes, Glucose Health(R) Daily Blood Sugar Maintenance, is now available in the "Diabetes Supplies" section at Walmart pharmacies nationwide, as well as online at walmart.com.
WMT: 71.52 (+0.06)

TriVita Launches Reformulated Glucose Health for Greater Blood Sugar Support
PRWeb - Tue Sep 15, 5:00AM CDT
In today's health-conscious world, it seems that everyone is looking for ways to optimize their health, starting with nutrition. TriVita, a North American nutraceutical firm based in Scottsdale, AZ, has launched the reformulation of their popular Amazon Herb supplement, Glucose Health. This proprietary blend of botanicals sourced from the Amazon Rainforest supports healthy blood sugar levels.

Glucose Health® Sales Update
PR Newswire - Mon Jun 29, 7:15AM CDT
Glucose Health, Inc. (OTCQB: GLUC) ("Company" is pleased to provide the following interim sales update:

Glucose Health(R) - Type-2 Diabetes Category Disruptor
BusinessWire - Wed Jun 03, 7:15AM CDT
Glucose Health, Inc. ("GLUC" or the "Company" today announced the uploading of a new quarterly letter to shareholders which, among items relating to the achievement of various corporate milestones, highlights the disruptive characteristics of the Company's namesake product, Glucose Health(R) Natural Blood Sugar Maintenance:

Glucose Health(TM)- New OTC Product For Type-2 Diabetes Health And Wellness
PR Newswire - Wed May 27, 7:15AM CDT
Healthcare professionals now have a new OTC (over- the-counter) product designed for the 2 in 5 Americans the Centers for Disease Control and Prevention (CDC) now estimates will develop Type-2 diabetes1 in their lifetime - Glucose Health(TM) Natural Blood Sugar Maintenance.

Glucose Health, Inc. Announces New Natural Product for Type-2 Diabetes Market
BusinessWire - Thu May 21, 7:15AM CDT
Glucose Health, Inc. (OTCQB: GLUC) (the "Company" today announced completion of the first production run of Glucose Health(TM) Natural Blood Sugar Maintenance - an innovative new product targeting the Type-2 Diabetes consumer market segment.

Glucose Health, Inc. Appoints Respected Nutrition Scientist As Advisor
PR Newswire - Thu Jan 29, 7:00AM CST
Glucose Health, Inc. (OTC: GLUC) ("Company" today announced the appointment of Chandrasekhar Mallangi, Ph.D., as an advisor to the Company, through the signing of an Agreement with CMS Consulting LLC, of which Dr. Mallangi is a principal.

Glucose Health, Inc. Announces Initial Filing With US Patent & Trademark Office
GlobeNewswire - Tue Jan 27, 10:08AM CST
Glucose Health, Inc. (OTC:GLUC) ("Company" today announced the filing of its initial application for trademark protection related to its Glucose Health line of dietary products, with the United States Trademark and Patent Office www.uspto.gov (USPTO). If the Company's application is successful and a trademark is awarded by the USPTO, a legal presumption of the Company's ownership nationwide of Glucose Health, and the exclusive right to use a trademark on or in connection with all Glucose Health branded products, as set forth in the registration, will exist.

New Dietary Product For Type 2 Diabetics Developed By Former Nestle Scientist
ACCESSWIRE - Mon Jan 26, 5:40PM CST
Bentonville, AR / ACCESSWIRE / January 26, 2015 / The Supply Side, a column read by national retail chain buyers, recently profiled Glucose Health, Inc., a manufacturer of a new non-prescription dietary product for Type 2 diabetics developed by a former Nestle food scientist.

Glucose Health, Inc. Completes Implementation of FDA Good Manufacturing Practices
GlobeNewswire - Wed Jan 07, 8:00AM CST
Glucose Health, Inc. ("GLUC" or the "Company" today announced it has completed implementation of Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP). The Dietary Supplement (DS) CGMP rule in 21 CFR part 111 of the FDA's regulations requires companies which manufacture, package, label, or hold a dietary supplement to establish and follow current good manufacturing practice to ensure the quality of the dietary supplement and to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.

Glucose Health, Inc. To Upgrade To OTCQB® Venture Market
PR Newswire - Tue Dec 16, 7:15AM CST
Glucose Health, Inc. ("GLUC" or the "Company" today announced a series of corporate measures.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 4

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Waller Supports Fed's Strategic Interest Rate Adjustment

Updated Category News Views 141

Waller Backs Fed's Rate Adjustment Strategy In a recent conversation about the Federal Reserve's monetary policy, Board of Governors Member Christopher Waller provided insights into the FOMC's choice to cut interest rates by 50 basis points. This announcement drew considerable attention during an interview broadcasted on a well-known financial news channel. These remarks...

Continue Reading
BayCare Welcomes Lynnette A. Clinton as New Chief Information Officer

Updated Category News Views 268

BayCare Health System Welcomes Lynnette A. Clinton Lynnette A. Clinton has made a significant return to BayCare Health System, taking on the key role of Chief Information Officer (CIO). Having previously served as the vice president of applications, Clinton is recognized for her leadership skills and dedication to advancing healthcare technology. Leadership Role and...

Continue Reading
FLSmidth Announces Successful Share Buy-Back Transactions

Updated Category News Views 212

FLSmidth's Strategic Share Buy-Back Program FLSmidth & Co. A/S has embarked on a significant share buy-back initiative aimed at enhancing shareholder value and demonstrating confidence in its operational capabilities. The company, a leading supplier of technology and services to the global mining industry, announced a program that allows for the repurchase of shares up to...

Continue Reading
Patrick Industries Boosts Quarterly Dividend for Investors

Updated Category News Views 121

Patrick Industries Announces Dividend Increase Patrick Industries, Inc. (NASDAQ: PATK) recently revealed an increase in its quarterly cash dividend, a move that reflects the company's lasting commitment to its shareholders and the robustness of its operational model. This decision comes as part of the company's ongoing strategy to deliver rewarding returns to investors....

Continue Reading
Omega Healthcare: Leading the Way in Ambulatory RCM Services

Updated Category News Views 117

Omega Healthcare Celebrates Recognition in RCM Services Omega Healthcare has been honored with the prestigious 2026 Best in KLAS award, distinguishing itself as a top performer in Ambulatory RCM Services. With an outstanding overall performance score of 92.2, this recognition marks a significant milestone for the company, reflecting its commitment to delivering...

Continue Reading